Öztay, F. And Yılmaz, Ö. 2016. Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases. patents/WO2016159917A1 , vol.1, no.1 , 1-10.

Öztay, F., & Yılmaz, Ö., (2016). Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases. patents/WO2016159917A1 , vol.1, no.1, 1-10.

Öztay, Füsün, And Öznur Yılmaz. "Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases," patents/WO2016159917A1 , vol.1, no.1, 1-10, 2016

Öztay, Füsün And Yılmaz, Öznur. "Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases." patents/WO2016159917A1 , vol.1, no.1, pp.1-10, 2016

Öztay, F. And Yılmaz, Ö. (2016) . "Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases." patents/WO2016159917A1 , vol.1, no.1, pp.1-10.

@article{article, author={Füsün ÖZTAY And author={Öznur Yılmaz}, title={Dasatinib for use in the treatment, regression or decelerating the progress of fibrotic lung diseases}, journal={patents/WO2016159917A1}, year=2016, pages={1-10} }